1、Tan HW, Liu X, Bi XP, Xing SS, Li L, Gong HP, et al.. IL-18 overexpression promotes vascular inflammation and remodeling in a rat model of metabolic syndrome. Atherosclerosis,2010;208:350-357.
2、Liu X#, Shi HF, Tan HW, Wang XH, Zhou L, Gu JN. Decreased connexin 43 and increased fibrosis in atrial regions susceptible to complex fractionated atrial electrograms. Cardiology,2009;114:22-29.
3、Tan HW, Wang XH, Shi HF, Yang GS, Zhou L, Gu JN, Jiang WF, Liu X #. Efficacy, safety and outcome of catheter ablation for atrial fibrillation in octogenarians.. Int J Cardiol,2009;
4、Wang X, Liu X#, Shi H, Gu J, Sun Y, Zhou L, Hu W. Heart rhythm disorders and pacemakers: Pulmonary vein isolation combined with substrate modification for persistent atrial fibrillation treatment in patients with valvular heart diseases.. Heart,2009;95:1773-1783
5、Wang XH, Liu X#, Sun YM, Shi HF, Zhou L, Gu JN.. Pulmonary vein isolation combined with superior vena cava isolation for atrial fibrillation ablation: a prospective randomized study.. Europace,2008;10:600-605.
6、Wang XH, Shi HF, Sun YM, Gu JN, Zhou L, Liu X#. Circumferential pulmonary vein isolation: the role of key target sites. Europace,2008;10:197-204.
7、Wang XH, Liu X#, Sun YM, Gu JN, Shi HF, Zhou L, Hu W.. Early identification and treatment of PV re-connections: role of observation time and impact on clinical results of atrial fibrillation ablation. Europace,2007;9:481-486.
|
